| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.0006 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |